{"id":820534,"date":"2025-03-03T08:43:06","date_gmt":"2025-03-03T13:43:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/"},"modified":"2025-03-03T08:43:06","modified_gmt":"2025-03-03T13:43:06","slug":"tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/","title":{"rendered":"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve"},"content":{"rendered":"

<\/p>\n

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve<\/b><\/p>\n

\n– Patent based on state-of-the-art science of vagus nerve stimulation approach shows greater effect from personalization of treatment –<\/p>\n

FREMONT, Calif.–(BUSINESS WIRE<\/a>)–Tivic Health\u00ae Systems, Inc.<\/a><\/span> (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, announced today that it has filed a new patent application with the U.S. Patent Office. Patent No. 63,492,402, entitled \u201cMethod and Apparatus for Electrical Stimulation of the Vagus Nerve<\/i>,\u201d expands the claims and protection around the technology in advance of potential U.S. Food & Drug Administration approval and commercialization of Tivic\u2019s non-invasive cervical vagus nerve stimulation (VNS) device.<\/p>\n

\n\u201cThis patent for our VNS technology builds upon the findings from our sponsored research at the Feinstein Institute, which has demonstrated that tailoring key stimulation parameters to each study subject results in a meaningfully improved effect on measures of the autonomous nervous system,\u201d said Blake Gurfein, Tivic Health Chief Scientific Officer. \u201cWhen compared with other technologies that apply the same stimulation approach to all patients, we believe this improvement will enable Tivic Health to develop more effective device therapies, which will be a key differentiator and create compelling use cases for the indications we plan to target.\u201d<\/p>\n

About Tivic Health Systems, Inc.<\/b><\/p>\n

\nTivic Health is a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health. Tivic Health takes a multi-pronged approach to treating the root causes of diseases caused by immune dysregulation and dysautonomia. The combination of bioelectronic and biologic medicines allow Tivic to target disorders and disease via both neural pathways and molecular approaches.<\/p>\n

\nTivic Health\u2019s first FDA approved product ClearUP\u2122\u00a0is proven to treat sinus pain and pressure, and is available through online retailers and commercial distributors. For more information about Tivic Health, visit: https:\/\/ir.tivichealth.com<\/a>.<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

This press release may contain \u201cforward-looking statements\u201d that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cseek,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201cshould,\u201d \u201cwill\u201d \u201cwould,\u201d or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems Inc.\u2019s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate.<\/i>Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: statements regarding the future development of ncVNS treatment, Tivic Health\u2019s ability to commercialize products arising out of the ncVNS treatment, Tivic Health\u2019s plans to seek regulatory approval for such clinical products and Tivic Health\u2019s continued focus on developing ncVNS treatment, including in the epilepsy, post-traumatic stress disorder, and\/or ischemic stroke space; expected clinical utility including which patient populations may be pursued; market and other conditions; supply chain constraints; macroeconomic factors, including inflation; unexpected costs, charges or expenses that reduce Tivic Health\u2019s capital resources; and Tivic Health\u2019s ability to maintain its Nasdaq listing. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Tivic Health\u2019s actual results to differ from those contained in the forward-looking statements, see Tivic Health\u2019s filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 29, 2024, under the heading \u201cRisk Factors\u201d; as well as the company\u2019s subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.<\/i><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250303313169\/en\/<\/a><\/span><\/p>\n

Investor Contact:
\n<\/b>
Hanover International, Inc.
\n
ir@tivichealth.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Alternative Medicine Health Medical Devices<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve – Patent based on state-of-the-art science of vagus nerve stimulation approach shows greater effect from personalization of treatment – FREMONT, Calif.–(BUSINESS WIRE)–Tivic Health\u00ae Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, announced today that it has filed a new patent application with the U.S. Patent Office. Patent No. 63,492,402, entitled \u201cMethod and Apparatus for Electrical Stimulation of the Vagus Nerve,\u201d expands the claims and protection around the technology in advance of potential U.S. Food & Drug Administration approval and commercialization of Tivic\u2019s non-invasive cervical vagus nerve stimulation (VNS) device. \u201cThis patent for … <\/p>\n

Continue reading “Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-820534","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve – Patent based on state-of-the-art science of vagus nerve stimulation approach shows greater effect from personalization of treatment – FREMONT, Calif.–(BUSINESS WIRE)–Tivic Health\u00ae Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, announced today that it has filed a new patent application with the U.S. Patent Office. Patent No. 63,492,402, entitled \u201cMethod and Apparatus for Electrical Stimulation of the Vagus Nerve,\u201d expands the claims and protection around the technology in advance of potential U.S. Food & Drug Administration approval and commercialization of Tivic\u2019s non-invasive cervical vagus nerve stimulation (VNS) device. \u201cThis patent for … Continue reading "Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T13:43:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve\",\"datePublished\":\"2025-03-03T13:43:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/\"},\"wordCount\":745,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/\",\"name\":\"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-03-03T13:43:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/","og_locale":"en_US","og_type":"article","og_title":"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - Market Newsdesk","og_description":"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve – Patent based on state-of-the-art science of vagus nerve stimulation approach shows greater effect from personalization of treatment – FREMONT, Calif.–(BUSINESS WIRE)–Tivic Health\u00ae Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, announced today that it has filed a new patent application with the U.S. Patent Office. Patent No. 63,492,402, entitled \u201cMethod and Apparatus for Electrical Stimulation of the Vagus Nerve,\u201d expands the claims and protection around the technology in advance of potential U.S. Food & Drug Administration approval and commercialization of Tivic\u2019s non-invasive cervical vagus nerve stimulation (VNS) device. \u201cThis patent for … Continue reading \"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-03T13:43:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve","datePublished":"2025-03-03T13:43:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/"},"wordCount":745,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/","name":"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-03-03T13:43:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250303313169r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-files-patent-for-optimized-electrical-stimulation-of-the-vagus-nerve\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=820534"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/820534\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=820534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=820534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=820534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}